معرفی
Professor Philip Andrews is a distinguished academic at Monash University's School of Chemistry, serving as Professor and Interim Head. His research focuses on discovering bioactive metal compounds, antimicrobial agents, and medical imaging technologies. He holds affiliations with the Monash Centre to Impact AMR and the Victorian Heart Institute. Andrews completed his PhD at the University of Strathclyde (1992) and has held prestigious fellowships, including Alexander von Humboldt and Royal Society awards. His work spans organometallic chemistry, medicinal chemistry, and sustainable chemistry, contributing to UN SDGs in health and sustainability.
Education
- PhD in Chemistry, University of Strathclyde (1992), Thesis: 'Synthesis and Characterisation of Novel Alkali Metal Amides.'
Research Interests
Andrews’ research integrates chemistry with medicine and sustainability, emphasizing:
- Development of metal-based antimicrobial agents targeting drug-resistant pathogens like Klebsiella and Leishmania.
- Design of bismuth and gallium complexes for medical imaging and therapeutics.
- Green synthesis methods, including microwave-assisted and solvent-free approaches.
Grants & Projects
He leads major projects like the ARC Training Centre for Advanced Radiochemical Technologies (2024–2029) and Combating Antimicrobial Resistance with Bismuth, Gallium, and Indium (2022–2026). His collaborations span global institutions, addressing AMR and sustainable materials.
Awards
- Recipient of the 2022 prize 'From grave to cradle: Hunting new antimicrobials through sustainable drug discovery.'
- Fellow of the Royal Society of Chemistry and Royal Australian Chemical Institute.
Labs & Teams
Andrews directs interdisciplinary teams advancing antimicrobial materials and medical imaging agents, with active partnerships in industry and academia.
